Standard BioTools Inc
NASDAQ:LAB

Watchlist Manager
Standard BioTools Inc Logo
Standard BioTools Inc
NASDAQ:LAB
Watchlist
Price: 1.05 USD -3.67% Market Closed
Market Cap: 398.8m USD

Intrinsic Value

The intrinsic value of one LAB stock under the Base Case scenario is 0.64 USD. Compared to the current market price of 1.05 USD, Standard BioTools Inc is Overvalued by 39%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

LAB Intrinsic Value
0.64 USD
Overvaluation 39%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Standard BioTools Inc

Valuation History Unavailable

Historical valuation for LAB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare LAB to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about LAB?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Standard BioTools Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Standard BioTools Inc

Current Assets 344m
Cash & Short-Term Investments 258.1m
Receivables 35.5m
Other Current Assets 50.5m
Non-Current Assets 235.6m
PP&E 71m
Intangibles 139.8m
Other Non-Current Assets 24.8m
Efficiency

Free Cash Flow Analysis
Standard BioTools Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Standard BioTools Inc

Revenue
169.7m USD
Cost of Revenue
-89.9m USD
Gross Profit
79.8m USD
Operating Expenses
-206.1m USD
Operating Income
-126.3m USD
Other Expenses
-6.4m USD
Net Income
-132.8m USD
Fundamental Scores

LAB Profitability Score
Profitability Due Diligence

Standard BioTools Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
Exceptional 1-Year Revenue Growth
Positive 3-Years Revenue Growth
26/100
Profitability
Score

Standard BioTools Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.

LAB Solvency Score
Solvency Due Diligence

Standard BioTools Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
55/100
Solvency
Score

Standard BioTools Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LAB Price Targets Summary
Standard BioTools Inc

Wall Street analysts forecast LAB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LAB is 2.42 USD with a low forecast of 2.27 USD and a high forecast of 2.63 USD.

Lowest
Price Target
2.27 USD
116% Upside
Average
Price Target
2.42 USD
131% Upside
Highest
Price Target
2.63 USD
150% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Standard BioTools Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for LAB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

LAB News

Other Videos
What is the Intrinsic Value of one LAB stock?

The intrinsic value of one LAB stock under the Base Case scenario is 0.64 USD.

Is LAB stock undervalued or overvalued?

Compared to the current market price of 1.05 USD, Standard BioTools Inc is Overvalued by 39%.

Back to Top